Substance use disorder affects 28.3 million people aged 12 and older in the United States. Illicit drug use generates 740 billion dollars in annual costs from healthcare, crime, and lost productivity. Data on addiction rates, treatment outcomes, and enforcement reveal distinct patterns across different substances.
Key Takeaways
- 28.3 million people aged 12+ had substance use disorder in U.S. 2022
- Illicit drug use costs the U.S. $740 billion annually in healthcare, crime, and lost productivity
- Fentanyl-involved overdose deaths rose 22% from 2021 to 2022, totaling 73,838 in the U.S.
- U.S. federal drug arrests totaled 1.2 million in 2022, mostly possession
- In 2022, 70.4 million people aged 12 or older (24.9% of the U.S. population) reported past year misuse of prescription pain relievers
Drug statistics show rising harm in recent years, underscoring the urgent need for effective prevention.
Related reading
01 · Category
Addiction and Treatment16 stats
01
28.3 million people aged 12+ had substance use disorder in U.S. 2022
02
Only 21.2% of people with opioid use disorder received medications for addiction in 2021
03
Methamphetamine use disorder treatment completion rate: 40-60% with contingency management
04
Alcohol use disorder remission rate: 36% within one year with treatment
05
Cocaine addiction recovery: 50% relapse within 1 year post-treatment
06
Heroin users entering treatment: average 7 years of use prior
07
Buprenorphine treatment reduces opioid overdose risk by 38%
08
Cannabis use disorder affects 10% of regular users, 16% of daily users
09
U.S. behavioral health treatment facilities: 17,581 serving 5 million annually
10
Nicotine addiction treatment success: 25-30% long-term quit rate with varenicline
11
MDMA-assisted therapy for PTSD: 67% remission rate in phase 3 trials
12
Inhalant addiction recovery challenging, with 50% relapse in first month
13
Kratom withdrawal similar to opioids, treated with buprenorphine in 70% cases
14
LSD tolerance develops rapidly, but psychological dependence low at 5%
15
Contingency management boosts stimulant treatment retention by 50-100%
16
MAT for alcohol (naltrexone) reduces heavy drinking days by 25%
Interpretation
Addiction and Treatment Interpretation
These statistics paint a stark picture of a nation struggling with addiction, where proven treatments like medication and contingency management are woefully underutilized lifelines that we must urgently extend to more people.
02 · Category
Economic Costs17 stats
01
Illicit drug use costs the U.S. $740 billion annually in healthcare, crime, and lost productivity
02
Opioid crisis economic burden: $1.02 trillion in U.S. from 2015-2020
03
Alcohol misuse costs U.S. $249 billion yearly in healthcare and lost productivity
04
Methamphetamine economic impact: $23.4 billion annually in U.S. healthcare and crime
05
Cocaine production and trafficking generate $88 billion in global illicit revenue yearly
06
U.S. prescription opioid misuse costs $78.5 billion per year in healthcare alone
07
Global cannabis market illicit value: $75 billion annually
08
Heroin-related crime costs U.S. $50 billion annually in enforcement and victimization
09
Treatment for substance use disorders costs U.S. $42 billion yearly
10
Lost productivity from drug use disorders: 194 million lost workdays in U.S. annually
11
Fentanyl crisis adds $1,500per capita healthcare cost in high-burden U.S. states
12
Global amphetamines trafficking revenue: $40 billion per year
13
MDMA/ecstasy market value: $5-10 billion globally illicit sales annually
14
Inhalant-related emergency visits cost U.S. $2.5 billion yearly
15
Kratom-related hospitalizations cost $50 million annually in U.S.
16
Workplace drug testing saves U.S. employers $1 billion yearly in accident prevention
17
U.S. spends $15 billion annually on drug-related incarceration
Interpretation
Economic Costs Interpretation
America's addictions are essentially running a monstrous, trillion-dollar shadow economy where the only products are ruin, the only growth is in suffering, and every citizen is an unwitting shareholder footing the bill.
03 · Category
Health Impacts15 stats
01
Fentanyl-involved overdose deaths rose 22% from 2021 to 2022, totaling 73,838 in the U.S.
02
Opioid use disorder led to 81,806 overdose deaths in the U.S. in 2022
03
Methamphetamine-involved overdose deaths increased to 36,466 in the U.S. in 2022
04
Cocaine overdose deaths reached 27,569 in the U.S. in 2022, up 8% from prior year
05
Alcohol contributes to 178,000 annual deaths in the U.S., including 49% of liver disease deaths
06
Cannabis use associated with 22% increased risk of schizophrenia in genetically predisposed youth
07
Heroin injection leads to HIV infection in 9% of U.S. users annually without prevention
08
Benzodiazepine misuse triples risk of opioid overdose death, per U.S. studies
09
Chronic methamphetamine use causes 40-50% dopamine transporter loss in brain scans
10
MDMA use linked to 3.2-fold increase in depression risk long-term
11
Prescription opioid misuse initiates 80% of heroin users' opioid journeys in U.S.
12
Inhalant abuse causes sudden death in 100-125 U.S. teens annually via cardiac arrhythmia
13
Kratom overdose deaths rose to 1,805 in the U.S. from 2017-2021, often polydrug
14
LSD rarely causes direct overdose but flashbacks persist in 20% of heavy users
15
U.S. drug overdose deaths totaled 109,680 in 2023, 75% involving synthetic opioids like fentanyl
Interpretation
Health Impacts Interpretation
It appears we are hosting a grim Olympics where the medals are measured in body counts and the only record we keep breaking is our own national tragedy.
More related reading
04 · Category
Legal and Policy15 stats
01
U.S. federal drug arrests totaled 1.2 million in 2022, mostly possession
02
42 U.S. states legalized medical cannabis by 2023, covering 93% population
03
DEA Schedule I drugs include heroin, LSD, marijuana, ecstasy per Controlled Substances Act
04
Global opium production hit 6,800 tons in 2022, mainly Afghanistan
05
U.S. opioid prescribing declined 44% from 2011 peak to 2022
06
24 states have decriminalized small amounts of drugs as of 2023
07
Fentanyl declared Schedule I, but analogs challenge enforcement
08
International treaties like 1961 UN Single Convention control 330 drugs
09
U.S. spends $47 billion yearly on drug law enforcement
10
Portugal's 2001 decriminalization reduced overdose deaths by 80% per capita
11
Cannabis legalization in Canada led to 35% drop in illegal market share by 2022
12
Methamphetamine precursors like pseudoephedrine regulated under Combat Meth Act 2005
13
Psychedelic therapy legalization efforts: Oregon Measure 109 passed 2020 for psilocybin
14
U.S. needle exchange programs operate in 37 states despite federal restrictions
15
Global cocaine seizures: 1,400 tons in 2022, led by Colombia
Interpretation
Legal and Policy Interpretation
The American legal landscape presents a bizarre contradiction, where a person can be federally arrested for possessing a plant that their state not only sells in stores but also prescribed by their doctor, all while our enforcement spending soars despite evidence that treating drugs as a health issue saves lives.
05 · Category
Prevalence and Usage16 stats
01
In 2022, 70.4 million people aged 12 or older (24.9% of the U.S. population) reported past year misuse of prescription pain relievers
02
Globally, 296 million people used cannabis in 2021, representing 5.8% of the adult population aged 15-64
03
In the United States, 48.7 million people aged 12 or older (17.3%) used illicit drugs in the past year in 2022
04
Lifetime prevalence of cocaine use among U.S. adults aged 12+ reached 22.8 million people (8.1%) in 2022
05
Methamphetamine use disorder affected 2.5 million people worldwide in 2019
06
In Europe, 8.4 million adults aged 15-64 reported past-year cannabis use in 2022
07
Heroin use in the past year was reported by 828,000 U.S. individuals aged 12+ in 2022
08
Amphetamine-type stimulants were used by 34 million people globally in 2021 (0.7% of adults 15-64)
09
Past-month hallucinogen use among U.S. youth aged 12-17 was 1.1% (289,000 people) in 2022
10
Inhalant misuse in the past year affected 2.3 million U.S. people aged 12+ (0.8%) in 2022
11
Sedative misuse past year prevalence was 5.4 million (1.9%) among U.S. adults 12+ in 2022
12
Ecstasy/MDMA past-year use: 2.7 million U.S. people aged 12+ (1.0%) in 2022
13
Kratom use in past year: 1.7 million U.S. adults 12+ (0.6%) in 2022
14
LSD past-year use: 0.9 million U.S. people 12+ (0.3%) in 2022
15
Past-month alcohol use disorder affected 28.9 million U.S. people 12+ (10.2%) in 2022
16
Nicotine vaping past-month use among U.S. high school students: 10.0% in 2023
Interpretation
Prevalence and Usage Interpretation
Our collective preoccupation with the substances we prohibit often distracts from the more pervasive, and often legally sanctioned, tragedies of alcohol and nicotine, revealing a society curiously adept at fighting some addictions while quietly drowning in others.
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Karl Becker. (2026, February 13). Drug Statistics. Gitnux. https://gitnux.org/drug-statistics
MLA
Karl Becker. "Drug Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/drug-statistics.
Chicago
Karl Becker. 2026. "Drug Statistics." Gitnux. https://gitnux.org/drug-statistics.
Sources & references
20 datasets cited across this report